Full text
Earnings transcript
Read the complete earnings call transcript.
AEHR
Aehr Test Systems
$44.32
4.72
(11.92%)
| Exchange: | NASDAQ |
| Market Cap: | 1.357B |
| Shares Outstanding: | 4.297M |
About The Company
| Sector: | Technology | |||||
| Industry: | Semiconductors | |||||
| CEO: | Gayn Erickson | |||||
| Full Time Employees: | 115 | |||||
| Address: |
| |||||
| Website: | https://www.aehr.com |
Aehr Test Systems provides test systems for burning-in and testing logic, optical, and memory integrated circuits worldwide. It offers products, such as the ABTS and FOX-P families of test and burn-in systems and FOX WaferPak Aligner, FOX-XP WaferPak Contactor, FOX DiePak Carrier, and FOX DiePak Loader. The ABTS system is used in production and qualification testing of packaged parts for lower power and higher power logic devices, as well as various common types of memory devices. The FOX-XP and FOX-NP systems are wafer contact and singulated die/module test and burn-in systems used for burn-in and functional test of complex devices, such as memories, digital signal processors, microprocessors, microcontrollers, systems-on-a-chip, and integrated optical devices. The FOX-CP system is a single-wafer compact test and reliability verification solution for logic, memory, and photonic devices. The WaferPak Contactor contains a unique full wafer probe card capable of testing wafers up to 300mm that enables IC manufacturers to perform test and burn-in of full wafers on Aehr Test FOX systems. The DiePak Carrier is a reusable, temporary package that enables IC manufacturers to perform final test and burn-in of bare die and modules. Aehr Test Systems was incorporated in 1977 and is headquartered in Fremont, California.
Click to read more…
Revenue Segmentation
EPS
Historical EPS and analyst estimates in one chart. Log in for the full interactive view and links to detailed estimates.
Earnings Call
AI summary
Key takeaways
Short, structured highlights from the call so you can focus on what matters.
Log in to continue
Log in to read the full transcript and AI-generated earnings summaries.
Login — it's freeIncome Statement
| Year | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | 64,961 | 66,218 | 58,968 |
| Gross Profit | 32,746 | 32,543 | 23,933 |
| EBITDA | 15,067 | 13,821 | -903 |
| Operating Income | 13,375 | 10,078 | -4,313 |
| Net Income | 14,557 | 33,156 | -3,910 |
(* All numbers are in thousands)
Balance Sheet
| Year | 2023 | 2024 | 2025 |
|---|---|---|---|
| Total Assets | 98,143 | 127,912 | 148,508 |
| Total Liabilities | 22,543 | 16,319 | 25,637 |
| Total Stockholders Equity | 75,600 | 111,593 | 122,871 |
| Total Debt | 6,300 | 6,197 | 10,830 |
| Cash and Cash Equivalents | 30,054 | 49,159 | 24,529 |
(* All numbers are in thousands)
Cash Flow Statement
| Year | 2023 | 2024 | 2025 |
|---|---|---|---|
| Operating Cash Flow | 10,011 | 1,756 | -7,400 |
| Capital Expenditure | -1,362 | -749 | -4,992 |
| Free Cash Flow | 8,649 | 1,007 | -12,392 |
| Net Income | 14,557 | 33,156 | -3,910 |
| Net Change in Cash | -1,360 | 19,105 | -22,829 |
(* All numbers are in thousands)
Analyst Estimates
| Fiscal Year | 2030 | Full Access | Full Access | Full Access | Full Access |
|---|---|---|---|---|---|
| Estimated Revenue (Low) | 188,802.677 | Full Access | Full Access | Full Access | Full Access |
| Estimated Revenue (High) | 200,963.166 | Full Access | Full Access | Full Access | Full Access |
| Estimated Revenue (Avg) | 196,103 | Full Access | Full Access | Full Access | Full Access |
| Estimated Ebitda (Low) | 19,173.584 | Full Access | Full Access | Full Access | Full Access |
| Estimated Ebitda (High) | 20,408.525 | Full Access | Full Access | Full Access | Full Access |
| Estimated Ebitda (Avg) | 19,914.958 | Full Access | Full Access | Full Access | Full Access |
| Estimated Net Income (Low) | 32,090.357 | Full Access | Full Access | Full Access | Full Access |
| Estimated Net Income (High) | 34,808.851 | Full Access | Full Access | Full Access | Full Access |
| Estimated Net Income (Avg) | 33,722.341 | Full Access | Full Access | Full Access | Full Access |
| Estimated SGA Expense (Low) | 48,729.817 | Full Access | Full Access | Full Access | Full Access |
| Estimated SGA Expense (High) | 51,868.429 | Full Access | Full Access | Full Access | Full Access |
| Estimated SGA Expense (Avg) | 50,614.024 | Full Access | Full Access | Full Access | Full Access |
| Estimated EPS (Avg) | 1.140 | Full Access | Full Access | Full Access | Full Access |
| Estimated EPS (High) | 1.180 | Full Access | Full Access | Full Access | Full Access |
| Estimated EPS (Low) | 1.080 | Full Access | Full Access | Full Access | Full Access |
| Number of Analysts (Estimated Revenue) | 1 | Full Access | Full Access | Full Access | Full Access |
| Number of Analysts (Estimated EPS) | 1 | Full Access | Full Access | Full Access | Full Access |
Log in to continue
Log in and subscribe to Full Access to see up to 5 years of analyst estimates.
Login — it's free(* All numbers are in thousands)
Current Key Metrics
Log in to continue
Log in to see all key valuation metrics and ratios for this symbol.
Login — it's freeForward P/E Ratios
Log in to continue
Log in with Full Access for forward P/E high/low estimates and the full multi-year table.
Login — it's freeSWOT Analysis
At what price to buy it? -
Intrinsic Value Calculator
Based on current fundamentals and analyst forecasts, MARKETSnap estimates AEHR intrinsic value between $0.47 – $0.50 per share. This depends on revenue growth, margins, and discount rate.
This is an automatic estimate. The most reliable way to know fair value for your own assumptions is to run the calculator below.
Common questions about AEHR valuation
Is AEHR (AEHR) overvalued or undervalued right now?
MARKETSnap estimates intrinsic value for AEHR (AEHR) using its proprietary valuation methodology, which incorporates discounted cash flow (DCF) analysis together with long-term earnings and fundamentals assumptions. By comparing intrinsic value to the current market price, long-term investors can see whether the stock screens as potentially overvalued, fairly valued, or undervalued today.
Is AEHR a buy, hold, or sell for long-term investors?
MARKETSnap does not give one-word “buy” or “sell” calls. Instead, it shows whether AEHR trades at a premium or discount to its estimated intrinsic value, how sensitive that value is to growth and margin assumptions, and how the stock fits into a diversified, long-term portfolio so investors can make their own buy, hold, or sell decision.
What is AEHR’s P/E ratio?
You can see AEHR’s trailing P/E (TTM) and forward P/E estimates in the Current Key Metrics and Forward P/E Ratios sections above. The P/E ratio compares the current share price to earnings per share and helps investors gauge valuation relative to earnings.
How is intrinsic value calculated for AEHR?
MARKETSnap uses its own valuation framework—not a generic spreadsheet DCF alone. Future cash flows and earnings are projected, discounted, and combined with MARKETSnap’s methodology so intrinsic value reflects fundamentals and long-term assumptions. You can run your own inputs and see the result using the Intrinsic Value Calculator above.
Is AEHR a good long-term investment?
Whether AEHR fits a long-term portfolio depends on your assumptions about growth, margins, and risk. MARKETSnap provides the metrics, intrinsic value calculator, and SWOT context so you can form your own view rather than rely on a single buy/sell rating.
AEHR
1-day price chart preview. Log in for 1W through 5Y ranges and period tabs.
11.92
Trading Metrics:
| Open: | Previous Close: | |||
| Day Low: | Day High: | |||
| Year Low: | Year High: | |||
| Price Avg 50: | Price Avg 200: | |||
| Volume: | Average Volume: |
Log in to continue
Log in for multi-period charts (1W–5Y), period tabs, and the same layout as members.
Login — it's freeCould not create stock discussion for AEHR
Relevant news
